This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03392/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03392/identifier/pubchem-compound/
n7http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB03392/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03392/identifier/drugbank/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03392
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB03392 n7:DB03392
dcterms:title
(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester
adms:identifier
n9:46936658 n10:46504665 n11:DB03392 n12:GL6
n5:IUPAC-Name
n6:271B43D0-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B43D6-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B43D5-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B43D2-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B43D3-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B43D4-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B43CE-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B43CC-363D-11E5-9242-09173F13E4C5 n6:271B43CF-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B43CD-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B43DC-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B43DD-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B43D7-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B43D8-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B43DA-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B43D9-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B43DB-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B43E2-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B43E4-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B43E5-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B43E1-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B43E0-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B43E3-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B43D1-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B43DE-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B43DF-363D-11E5-9242-09173F13E4C5